School of Life Science and Technology, University of Electronic Science and Technology
Chengdu, Sichuan, 611731, China
NCT Number: NCT02745431
The current study aimed to investigate oxytocin effect on the response after the experience of being liked or disliked.
Looking for future studies?
Notify Me18 year–30 year
Male
Interventional
Not applicable
Chengdu, Sichuan, 611731, China
In a double-blind, between-subject, placebo controlled design study, the researchers aimed to investigate the intranasal OXT (40IU) treatment on rating response after being liked or disliked in healthy male subjects. All subjects completed a range of questionnaires measuring personality and affective traits and levels of anxiety: Positive and Negative Affect Schedule (PANAS) , State-Trait Anxiety Inventory (STAI) , Beck Depression Inventory (BDI), Cheek and Buss shyness Scale (CBSS),Autism Spectrum Quotient (ASQ), Empathy Quotient(EQ) before self-administration.Study participants were led to believe that other participants had formed an opinion on their likability based on their appearance in a photograph and they passively viewed the responses (like or dislike) from 'other participants'. After that, they rated 'other participants' about likeability (how much do you like the person), accuracy (have you seen the person), feeling (how good do you feel), and tendency (how much would do like have him/her as a friend). Likeability, tendency, feeling and accuracy were included into analysis as dependent variables.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2 hour
Likeability rating was included into analysis as dependent factor.
Time frame: 2 hour
subjects were subdivided into two subgroups
University of Electronic Science and Technology of China
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04656990
Behavior, Gross Motor Development Delay
Swansea, South Carolina, United States
View Trial DetailsNCT06246734
Behavior, Behavioral Symptoms
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT05520047
Behavior, COVID-19
Metz, France
View Trial DetailsNCT06246058
Behavior, Consumer Behavior
Butha-Buthe, Lesotho
View Trial Details